May 6th 2024
Analysis reveals rising hospitalization rates among pregnant women with hepatitis C virus (HCV) and age as a critical factor influencing maternal and fetal health outcomes.
Hepatitis C Virus Retreatment Successful with SOF/VEL/VOX in Patients With and Without HIV
November 13th 2018A fixed-dose combination therapy (Vosevi, Gilead) was highly effective after 12 weeks in retreating direct-acting antiviral-experienced patients with hepatitis C virus infection, with and without HIV co-infection, including those with prior noncompletion of treatment or poor adherence.
Read More
Direct-Acting Antiviral Therapy Effective for Curing Hepatitis C in Injection Drug Users
September 24th 2018A recent study by the Kirby Institute reported that after using direct-acting antiviral therapy 97% of participants with HCV who recently used injectable drugs achieved sustained viral response.
Read More